CIBC Private Wealth Group
AVEO

CIBC Private Wealth Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

CIBC Private Wealth Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,700
Closed -$17K – 977
2019
Q4 		$17K Buy
2,700
+500
+23% +$3.68K ﹤0.01% 894
2019
Q3 		$19K Buy
2,200
+1,000
+83% +$7.44K ﹤0.01% 883
2019
Q2 		$8K Buy
+1,200
New +$10.3K ﹤0.01% 913
2018
Q3 		– Sell
-200
Closed -$5K – 1908
2018
Q2 		$5K Hold
200
– – ﹤0.01% 1742
2018
Q1 		$6K Hold
200
– – ﹤0.01% 1649
2017
Q4 		$6K Buy
+200
New +$6.21K ﹤0.01% 1669

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIBC Private Wealth Group's AVEO Position: Q1 2020 in Review

CIBC Private Wealth Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2020, closing a stake of 2,700 shares — an estimated $17K sold.

CIBC Private Wealth Group first reported a position in AVEO in Q4 2017 and held it in 6 quarters. The position peaked at $19K in Q3 2019. 35 funds tracked by Wall St. Rank hold AVEO as of Q1 2020.

  • CIBC Private Wealth Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • CIBC Private Wealth Group sold 2,700 AVEO Pharmaceuticals, Inc. shares in Q1 2020, an estimated $17K.
  • CIBC Private Wealth Group first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 6 quarters.
  • CIBC Private Wealth Group's AVEO Pharmaceuticals, Inc. position peaked at $19K in Q3 2019.
  • 35 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2020.

Based on CIBC Private Wealth Group's 13F filing for Q1 2020, filed 15 May 2020.